Results 151 to 160 of about 8,169,081 (300)

How to Create a Good Table (And Avoid Common Mistakes)

, 2016
Samir Kumar Praharaj
openalex   +2 more sources

State, citizenship, and common good: British idealists’ influence on social philosophy and planning culture [PDF]

, 2014
Luigi Mazza
openalex   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

"People are now working together for a common good": The effect on social capital of participatory design for community-level sanitation infrastructure in urban informal settlements. [PDF]

World Dev
Salinger AP, Charles I, Francis N, Batagol B, Meo-Sewabu L, Nasir S, Bass A, Habsji H, Malumu L, Marzaman L, Prescott MF, Jane Sawailau M, Syamsu S, Taruc RR, Tela A, Vakarewa I, Wilson A, Sinharoy SS, RISE Consortium.   +18 more
europepmc   +1 more source

The current crisis of academia-led research: a threat to the common good? Preliminary data from Europe and the United States. [PDF]

BMC Res Notes, 2020
Carta MG, Moro MF, Kirilov I, Romano F, Tagliagambe S.   +4 more
europepmc   +1 more source

Pursuing the common good in daily work: essays on public service motivation in Switzerland

, 2011
Simon Anderfuhren-Biget
openalex   +1 more source

Responses to Hollenbach: The Common Good and the Marginalized [PDF]

, 1998
Goizueta, Roberto S.
core   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Viewing health care as a common good: looking beyond political liberalism.

, 2000
Kevin P. Quinn
openalex   +1 more source